Alfa Chemistry Launches Structure-based Drug Design as an Essential Tool

NEW YORK - Nov. 15, 2022 - PRLog -- As an active player in the chemical industry, Alfa Chemistry decided to combine the power of computational chemistry with drug design and synthesis. This move aims to largely enhance the overall drug discovery efficiency and open up new possibilities for the pharmaceutical industry. Fairly recently, the company launched a series of structure-based drug design (SBDD) services, showing capabilities in virtual screening, flexible target sampling, skeleton transitions, de novo design, and more.

The abundance of studies on genomics and proteomics presents hundreds of new targets and opportunities for drug discovery attempts. However, it is very labor-intensive to process such "big data". Hence, computational chemistry makes its debut, serving as an essential tool to discover lead compounds more swiftly and less expensively.

Highlights of Alfa Chemistry's structure-based drug design services:

l A variety of skeleton transition methods are used to generate new patented compound sets with improved properties

l Utilizing the solute and solvation energy to optimize the binding affinity, thus predicting the natural binding mode of compounds

l Remarkably cost-efficient while holding promise for future research

The following SBDD techniques are available at Alfa Chemistry:

l Molecular docking

l Crystal structure prediction

l Homology modeling

l Structure-based virtual screening

l MD simulation

l Quantum mechanics (QM) calculation

l Fragment-based drug design (FBDD)

Among all computational techniques, structure-based virtual screening (SBVS), molecular docking, and molecular dynamics (MD) simulations are the most common strategies used in SBDD. Please visit the website to learn more.


Always putting customers' needs first, Alfa Chemistry has been intensifying its efforts to further enrich product and service portfolios. As an experienced service provider in chemical synthesis, Alfa Chemistry manages to strengthen the power of computational chemistry in drug discovery endeavors. In addition to the possession of a powerful team of experts in multiple disciplines, such as chemistry, biology, mathematics, crystallography, and pharmacology, the company is also committed to incorporating novel and advanced algorithms into its high-quality services, such as drug design and computer-aided chemical drug synthesis (, meeting diverse scientific needs.
Email:*** Email Verified
Tags:Structure-based Drug Design
Location:New York City - New York - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
alfachemistry News
Most Viewed
Daily News

Like PRLog?
Click to Share